Drug industry to drive speedy growth strategies

Most of the drug makers of the fiscal year ending at Mar. 31 announced speedy business growth strategies in the coming fiscal year ensuing the previous year, largely focusing on the so far neglected OTC drug markets.

They achieved a successful business growth in a double digit last year and set up ongoing growth stance this year too ranged about 15% of sales and over 10% of net profits unde...